Transduction of cell lines and primary cells by FIV-packaged HIV vectors

Molecular Therapy

Volumn 10, Issue 1, 2004, Pages 181-190

  Morris, Kevin V ^a   Gilbert, James ^b   Wong Staal, Frossie ^c   Gasmi, Mehdi ^d   Looney, David J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Immusol   (United States)

^d Ceregene Inc   (United States)

Author keywords

Feline immunodeficiency virus; Human immunodeficiency virus type 2; Lentiviral vectors; Lentivirus encapsidation

Indexed keywords

ANTIVIRUS AGENT; REV PROTEIN; RIBOZYME; RNA ANTIBODY; STRUCTURAL PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN; VIRUS RNA; VIRUS VECTOR;

ARTICLE; CELL LINE; CONTROLLED STUDY; DNA PACKAGING; FEASIBILITY STUDY; FELINE IMMUNODEFICIENCY VIRUS; GENE CASSETTE; GENE CONSTRUCT; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 2; RNA TRANSLATION; RNA TRANSPORT; SEQUENCE HOMOLOGY; SEROCONVERSION; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION;

CELL LINE; GENE PRODUCTS, REV; GENE PRODUCTS, TAT; GENETIC VECTORS; HIV-2; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; TRANSDUCTION, GENETIC; VIRUS ASSEMBLY; VIRUS INTEGRATION;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; LENTIVIRUS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 3042773732     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2004.03.019     Document Type: Article

References (34)

1. Lever, A. M. (2000). HIV RNA packaging and lentivirus-based vectors. Adv. Pharmacol. 48: 1-28.
2. Poeschla, E., Wong-Staal, F., Looney, D. J. (1998). Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat. Med. 4: 354-357.
3. Schnolzer, M., et al. (1996). Comparative properties of feline immunodeficiency virus (FIV) and human immunodeficiency virus type 1 (HIV-1) proteinases prepared by total chemical synthesis. Virology 224: 268-275.
4. Kemler, I. R. B., Poeschla, E. M. (2002). Encapsidation signal of feline immunodeficiency virus (FIV): mapping and significance for FIV vectors. Mol. Ther. 5: S174. [Conference Abstract 528].
5. Browning, M. T., Schmidt, R. D., Lew, K. A., Rizvi, T. A. (2001). Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions. J. Virol. 75: 5129-5140.
6. Loewen, N., et al. (2002). Preservation of aqueous outflow facility after second-generation FIV vector-mediated expression of marker genes in anterior segments of human eyes. Invest. Ophthalmol. Visual Sci. 43: 3686-3690.
7. Haskell, R. E., Hughes, S. M., Chiorini, J. A., Alisky, J. M., Davidson, B. L. (2003). Viralmediated delivery of the late-infantile neuronal ceroid lipofuscinosis gene, TPP-I to the mouse central nervous system. Gene Ther. 10: 34-42.
8. O'Rourke, J. P., Newbound, G. C., Kohn, D. B., Olsen, J. C., Bunnell, B. A. (2002). Comparison of gene transfer efficiencies and gene expression levels achieved with equine infectious anemia virus- and human immunodeficiency virus type-1-derived lentivirus vectors. J. Virol. 76: 1510-1515.
9. Berkowitz, R., et al. (2001). Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virus. J. Virol. 75: 3371-3382.
10. White, S. M., et al. (1999). Lentivirus vectors using human and simian immunodeficiency virus elements. J. Virol. 73: 2832-2840.
11. Cheng, L., et al. (2002). Human immunodeficiency virus type 2 (HIV-2) vector-mediated in vivo gene transfer into adult rabbit retina. Curr. Eye Res. 3: 196-201.
12. Poon, B., Chen, I. S. (2003). Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA. J. Virol. 77: 3962-3972.
13. Stevenson, M., Haggerty, S., Lamonica, C. A., Meier, C. M., Welch, S. K., Wasiak, A. J. (1990). Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J. Virol. 2421-2425.
14. Pauza, C. D., Galindo, J. (1989). Persistent human immunodeficiency virus type 1 infection of monoblastoid cells leads to accumulation of self-integrated viral DNA and to production of defective virions. J. Virol. 63: 3700-3707.
15. Masuda, T., et al. (1995). Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. J. Virol. 69: 6687-6696.
16. Nakajima, N., Lu, R., Engelman, A. (2001). Human immunodeficiency virus type 1 replication in the absence of integrase-mediated DNA recombination: definition of permissive and nonpermissive T-cell lines. J. Virol. 75: 7944-7955.
17. Wu, Y., and Marsh, J. W. (2001). Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science 293: 1503-1506.
18. Cara, A., et al. (1995). Self-limiting, cell type-dependent replication of an integrasedefective human immunodeficiency virus type 1 in human primary macrophages but not T lymphocytes. Virology 208: 242-248.
19. Arya, S. K. (1988). Human and simian immunodeficiency retroviruses: activation and differential transactivation of gene expression. AIDS Res. Hum. Retroviruses 4: 175-186.
20. Butera, S. T., et al. (2000). Survey of veterinary conference attendees for evidence of zoonotic infection by feline retroviruses. J. Am. Vet. Med. Assoc. 217: 1475-1479.
21. Johnston, J., Power, C. (1999). Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector development. J. Virol. 73: 2491-2498.
22. Johnston, J. B., Olson, M. E., Rud, E. W., Power, C. (2001). Xenoinfection of nonhuman primates by feline immunodeficiency virus. Curr. Biol. 11: 1109-1113.
23. Price, M. A., et al. (2002). Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells. Mol. Ther. 6: 645-652.
24. Gilbert, J. R., Wong-Staal, F. (2001). HIV-2 and SIV. In Lentiviral Vector Systems for Gene Transfers (G.L Buchschacher, Ed.), pp. 78- 93.
25. Poeschla, E., Gilbert, J., Li, X., Huang, S., Ho, A., Wong-Staal, F. (1998). Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors. J. Virol. 72: 6527-6536.
26. Ferrandez, A., Garcia, J. L., Diaze, E. (2000). Transcriptional regulation of the divergent PAA catabolic operons for phenylacetic acid degradation in Escherichia coli. J. Biol. Chem. 275: 12214-12222.
27. + progenitor cell-derived macrophages. Mol. Ther. 8: 62-71.
28. Rappaport, J. S. J. L., Kihalili, K., Wong-Staal, F. (1989). The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain. New Biol. 1: 101-110.
29. George, J. W., Pedersen, N. C., Higgins, J. (1993). The effect of age on the course of experimental feline immunodeficiency virus infection in cats. AIDS Res. Hum. Retroviruses 9: 897-905.
30. Sheeter, D., Du, P., Rought, S., Richman, D., Corbeil, J. (2003). Surface CD4 expression modulated by a cellular factor induced by HIV type 1 infection. AIDS Res. Hum. Retroviruses 19: 117-123.
31. Butler, S. L., Hansen, M. S. T., Bushman, F. D. (2001). A quantitative assay for HIV DNA integration in vivo. Nat. Med. 7: 631-634.
32. Chun, T. W., et al. (1997). Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94: 13193-13197.
33. Zufferey, R., et al. (1999). Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73: 2886-2892.
34. Talbott (1989).